Boots agrees £6.7bn sale to Canada's Weston family

What happened

Boots is set to pass into the ownership of Canada's Weston family under a £6.7bn agreement, putting the pharmacy and beauty retailer at the centre of another major change in British high street ownership.

Wittington Investments, the family's holding company, announced the transaction on Wednesday. It is buying the business from US private equity firm Sycamore Partners and the Pessina family in a deal valued at $8.9bn.

The acquisition extends beyond the familiar chemist shops. It covers Boots' retail businesses in the UK and Ireland, Boots Opticians, No7 Beauty Company, and the group's operations in Thailand and its franchised businesses. Those interests bring together shops, healthcare services and beauty products under the new ownership arrangement.

Wittington has joined forces with Toronto-based Fairfax Financial Holdings for the purchase and will have operational control. Fairfax is an investment holding company whose interests include a stake in the owner of mattress business Simba Sleep.

Two businesses will stay with the existing owners. Sycamore Partners and Stefano Pessina's family will retain Mexico's Farmacias Benavides and Germany's Alliance Healthcare Deutschland, rather than transferring them to the Weston-led partnership.

Boots has about 1,800 UK stores and employs 51,000 people. Its latest annual sales reached £7.5bn, an increase of 3.2% on 2024, giving the incoming owners a business whose revenues have continued to grow despite pressures on high street shopping.

The purchase price and annual sales measure different things: the former is the value attached to the transaction, while the latter records what the business sold during a year. Sales growth does not, by itself, show how much profit a retailer makes.

The background

Boots' history began in Nottingham in 1849, when John Boot opened a herbalist's shop. His business offered lower-cost alternatives to conventional medicines, establishing a connection with everyday healthcare that has survived its expansion into a much broader retailer.

Over 177 years, its shelves have come to include cosmetics, meal deals and travel accessories alongside health products. That combination means Boots competes across several shopping markets rather than relying solely on the work of its pharmacies.

Its healthcare activities also extend beyond selling medicines. Vaccinations, eye examinations and hearing tests form part of its services, and the company supported healthcare provision during the coronavirus pandemic. These activities place some of its customer relationships closer to clinical care than conventional retail shopping.

The Advantage Card arrived in 1997 and became a widely used part of the business. The loyalty scheme linked repeat shopping with rewards, a model that has since become familiar across much of the retail sector.

Boots' physical network has nevertheless contracted. Hundreds of branches have shut in recent years as the chain has adapted to competition and different shopping patterns. Working from home has reduced the flow of office workers through town and city centres, affecting visits to stores in those locations.

Beauty has provided a stronger area of demand. Korean beauty brands have attracted shoppers, while Boots has also targeted spending on wellness products, including vitamins and electrolyte supplements. Growing use of weight-loss injections has supplied another source of business.

The current ownership structure followed Sycamore's £7.4bn acquisition of Walgreens Boots Alliance. The private equity firm separated the former parent company's businesses, creating the Boots Group in the process. Stefano Pessina and his wife, Ornella Barra, continued to hold a 44% interest in Boots.

For the Canadian Westons, the acquisition adds to established interests in food and pharmacy retailing. Through Wittington, the family controls grocery chain Loblaws and pharmacy operator Shoppers Drug Mart, giving it experience of running businesses in two areas that overlap with Boots' activities.

The family also previously owned London department store Selfridges. Its Canadian business interests are distinct from those of the UK branch of the Weston family, which is the majority owner of Associated British Foods, the parent company of Primark.

What people are saying

Retail specialist Catherine Shuttleworth, chief executive of Savvy Marketing, regards the succession of ownership discussions and changes at Boots as a distraction from running the retailer. Several possible deals have been considered over the past two decades, with some completed and others remaining proposals.

Shuttleworth sees substantial scope for growth in health and beauty and believes investment from the incoming owners could help Boots benefit. Her assessment places the emphasis on developing the business rather than expecting an immediate transformation of its shops.

Stefano Pessina welcomed the agreement and expressed confidence in the buyers' ability to look after Boots' heritage. Reflecting on his and Ornella Barra's two-decade association with the company, he also thanked employees for their contribution during that period.

Danni Hewson, head of financial analysis at AJ Bell, highlighted a different consequence: the loss of a potential new listing for London's stock market. Boots had been seen as a possible high-profile addition at a time when such arrivals have been scarce.

A flotation would have offered public-market investors the opportunity to buy shares in a separately listed Boots business. The agreed sale instead provides a route to new ownership through a private transaction, ending the prospect of that stock market return under this deal.

What happens next

Completion is expected in early 2027. Wednesday's agreement therefore sets out a future transfer of ownership rather than marking the point at which the buyers have already taken over the business.

Galen Weston is due to become Boots' chairman. He has set out an approach based on sustained ownership and additional investment, with store improvements and a broader range of healthcare services among the priorities for the chain.

Those plans involve two different aspects of the customer experience: the condition and operation of shops, and the services people can obtain through them. Investment in the estate would concern the retail environment, while expanding healthcare would develop the service side of the business.

Alex Baldock, who became Boots' chief executive last month, is expected to remain in the role. He previously led Currys, where his work on the electronics retailer's recovery helped establish the reputation he brings to his new job.

Hewson expects the Westons to pursue greater efficiency alongside growth, potentially committing substantial funds to updating stores. Shuttleworth, meanwhile, expects relatively little visible change for shoppers over the coming months, with improvements emerging over a longer period as investment takes effect.

Why this matters

For UK customers, the practical significance lies in the combination of shopping and healthcare at local branches. If the planned expansion of services is delivered, the takeover could affect what people can access near home, not simply how shops look.

The agreement also links the future of a large British retail employer to an owner already active in Canadian pharmacy. For staff, the forthcoming transfer puts responsibility for investment and operating priorities with a new controlling business rather than a newly listed company.